DUBLIN--(BUSINESS WIRE)--The "Intraoperative Radiation Therapy Market by Method (Electron IORT, Intraoperative Brachytherapy), Products & Services (Accelerators, Treatment Planning System, Applicators, Afterloaders, Accessories), Application (Breast, Brain) - Global Forecasts to 2024" report has been added to ResearchAndMarkets.com's offering.
The global intraoperative radiation therapy market is projected to reach USD 68 million by 2024 from USD 48 million in 2019, at a CAGR of 7.0%.
The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.
However, the complex nature of technology coupled with a shortage of trained personnel and preference of conventional radiotherapy over IORT by physicians owing to reimbursement coverage are the major factors that are expected to restrain the growth of this market.
The system/accelerators segment is expected to account for the largest market share during the forecast period
Based on product type, the intraoperative radiation therapy market products market is segmented into system/accelerators, treatment planning systems, applicators & after loaders, and accessories. The systems/accelerators segment is expected to account for the largest share of the IORT products market in 2019. The large share of this segment can be attributed to the low cost of accelerators as compared to advanced radiosurgery products, growing applications of IORT products in cancer treatment, and the development of technologically advanced mobile systems/accelerators.
The breast cancer segment is expected to hold the largest share of the intraoperative radiation therapy market, by application, during the forecast period
Based on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head & neck cancer, and other cancers. The breast cancer segment is expected to account for the largest share of this market in 2019. The large share of this segment can be attributed to a high prevalence of breast cancer, coupled with advantages offered by IORT such as the reduced amount of irradiation, shorter treatment time, and lesser clinical risks.
- Growing Global Prevalence of Cancer
- Technological Advancements
- Advantages of IORT Over EBRT
- Complexity of Technology and Shortage of Trained Personnel
- Preference for Conventional Radiotherapy Over IORT
- Growing Applications of IORT
- Ariane Medical Systems, Ltd.
- Eckert & Ziegler
- Elekta AB
- GMV Innovating Solutions
- ICAD, Inc.
- Intraop Medical Corporation
- Sensus Healthcare, Inc.
- Sordina IORT Technologies S.P.A.
- Varian Medical Systems, Inc.
- Zeiss Group
For more information about this report visit https://www.researchandmarkets.com/r/kquj90